Mannkind (MNKD) Non-Current Assets (2010 - 2026)

Mannkind (MNKD) reported Non-Current Assets of $493.2 million for Q1 2026, up 261.6% year-over-year from $136.4 million in Q1 2025, and down 1.47% quarter-over-quarter from $500.6 million in Q4 2025.

Mannkind (MNKD) Non-Current Assets (2010 - 2026) Analysis & Trends

Mannkind (MNKD) has 17 years of Non-Current Assets data on file, last reported at $493.2 million in Q1 2026.

  • Non-Current Assets for Q1 2026 came in at $493.2 million, up 261.6% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.3 billion (up 144.46% YoY), and the FY2025 annual result was $500.6 million, up 298.77% from the prior year.
  • Non-Current Assets declined to $493.2 million in Q1 2026 per MNKD's latest filing, from $500.6 million in the prior quarter.
  • Over five years, Non-Current Assets peaked at $500.6 million in Q4 2025 and troughed at $60.4 million in Q4 2022.
  • A 5-year average of $152.0 million and a median of $117.9 million in 2024 frame the typical range for Non-Current Assets.
  • On a YoY basis, Non-Current Assets climbed as much as 299.66% in 2022 and fell as far as 40.61% in 2022.
  • A 5-year view of Non-Current Assets shows it stood at $60.4 million in 2022, then soared by 68.59% to $101.8 million in 2023, then increased by 23.31% to $125.5 million in 2024, then soared by 298.77% to $500.6 million in 2025, then slipped by 1.47% to $493.2 million in 2026.
  • Business Quant data shows MNKD's Non-Current Assets at $493.2 million in Q1 2026, $500.6 million in Q4 2025, and $135.8 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 62,953.78
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 289.41 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 4.56 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 486.60 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 30.30 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 5.18 Mn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 14.75 Bn
9 Abivax 91.96 Bn 91.96 Bn - 39.71 Mn
10 Mannkind 1.21 Bn 1.08 Bn 82.66 Mn 493.24 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 493.24 Mn
Dec 31, 2025 500.60 Mn
Sep 30, 2025 135.80 Mn
Jun 30, 2025 132.67 Mn
Mar 31, 2025 136.40 Mn
Dec 31, 2024 125.54 Mn
Sep 30, 2024 136.54 Mn
Jun 30, 2024 117.90 Mn
Mar 31, 2024 97.78 Mn
Dec 31, 2023 101.81 Mn
Sep 30, 2023 94.75 Mn
Jun 30, 2023 83.19 Mn
Mar 31, 2023 74.84 Mn
Dec 31, 2022 60.39 Mn
Sep 30, 2022 75.46 Mn
Jun 30, 2022 92.32 Mn
Mar 31, 2022 124.05 Mn
Dec 31, 2021 101.67 Mn
Sep 30, 2021 79.00 Mn
Jun 30, 2021 72.89 Mn